Facebook
X
LinkedIn
Forward
Next-Generation HIV PrEP: Therapeutic Advances, Adherence Optimization, and Policy Updates for Managed Care
Pricing: Free for Members and Non-Members
Course Description
Human Immunodeficiency Virus (HIV) remains a significant public health challenge in the United States, with approximately 1.2 million individuals living with HIV as of 2023. The landscape of HIV prevention has transformed with various PrEP formulations and extended-dosing regimens, offering a diverse array of options that enable clinicians to tailor prevention strategies to individual patient needs, preferences, and lifestyles for optimal adherence and efficacy. This session will explore how managed care organizations can play a transformative role in maximizing the prevention impact of HIV PrEP by ensuring equitable access and implementation of guidelines, so that all individuals, regardless of race or ethnicity, who may benefit from PrEP are appropriately identified and offered this highly effective prevention strategy. This session will provide an overview of newly emerging extended dosing HIV PrEP injectables, HIV policy updates to align public health initiatives, and PrEP adherence strategies for managed care organizations.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Distinguish the new and emerging long-acting therapies for the prevention of HIV, including clinical efficacy, safety administration, and adherence considerations.
- Review current health policies affecting HIV prevention to guide managed care organizations in developing actionable strategies to improve equitable PrEP access and align with public health goals.
- Discuss managed care strategies to support patients at risk of HIV to improve access, adherence, and health outcomes.
Kelsea Aragon, PharmD, PhC, BCACP, CDCES, AAHIVP
Associate Professor of Pharmacy Practice
University of New Mexico College of Pharmacy
Julie Kendle, PharmD
Senior Director, Clinical Pharmacy
IPD Analytics
Disclosures
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Kelsea Aragon Faculty | Disclosed no relevant financial relationshiops |
| Julie Kendle Faculty | Individual Stocks/Stock Options, CVS Health |
| Casey Koch Peer Reviewer | Disclosed no relevant financial relationships |
| Brooke Whittington Planner | Disclosed no relevant financial relationships |
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 0233-0000-26-004-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: April 20, 2026 • Expiration Date: December 31, 2027
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2026. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.